Gilead Sciences
GILD
#132
Rank
C$231.07 B
Marketcap
C$186.11
Share price
4.21%
Change (1 day)
22.97%
Change (1 year)

EPS for Gilead Sciences (GILD)

EPS in 2025 (TTM): C$9.50

According to Gilead Sciences's latest financial reports the company's current EPS (TTM) is C$9.71. In 2024 the company made an earnings per share (EPS) of C$0.54 a decrease over its 2023 EPS that were of C$6.45.

EPS history for Gilead Sciences from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C$9.501662.72%
2024C$0.54-91.65%
2023C$6.4523.98%
2022C$5.20-25.86%
2021C$7.024850%
2020C$0.14-97.64%
2019C$6.010.9%
2018C$5.9618.71%
2017C$5.02-64.88%
2016C$14.29-18.45%
2015C$17.5255.28%
2014C$11.29296.02%
2013C$2.8517.89%
2012C$2.42

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$12.39 27.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$1.86-80.88%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
C$2.92-69.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$40.02 312.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$20.53 111.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$13.26 36.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
C$7.84-19.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
C$24.12 148.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$5.04-48.07%๐Ÿ‡บ๐Ÿ‡ธ USA